STUART, FL – March, 2017 – The iRemedy Healthcare Companies, Inc. today announced the addition of Adam Landsman, DPM, PhD to iRemedy’s Medical Advisory Board.
“Adam is widely recognized as an important and strategic advisor for companies developing new clinical and product solutions, especially for wound care and podiatric treatments. As we increase our commitment to the podiatric and wound care communities his thought leadership will be extremely valuable”, stated Tony Paquin, CEO of Paquin Healthcare.
In addition to his role as Chief of Podiatric Surgery at Cambridge Health, Adam has also been a member of various associations including the American Diabetes Association, the America Podiatric Medical Association, the American Board of Podiatric Surgery, and the American College of Foot and Ankle Surgeons where he has served on the Board of Directors and Chair of their Research Committee.
“We are very focused on further developing our podiatric community at iRemedy. It is essential that we represent the very best in product and clinical solutions, and Dr. Landsman will be an essential part of our leadership as we seek innovations that serve our ‘Smarter Supply and Better Care’ mission,” Paquin stated.
“I am excited to join the iRemedy team. I think that their model for sales and distribution of medical products and devices is right on target for today’s physicians. Like Amazon, iRemedy can reach physicians anywhere, and their broad portfolio will bring the latest technologies at the best possible prices,” said Dr. Landsman.
Dr. Landsman has provided management services to several healthcare product startups and served as an advisor to many more. He is a nationally recognized speaker and has appeared in academic, industry and consumer media. Dr. Landsman received his DPM from Temple University and his PhD from the University of Pennsylvania, and currently has an academic appointment as an Assistant Professor Surgery at Harvard University.
About The iRemedy Healthcare Companies, Inc.
Headquartered in Stuart, Florida, The iRemedy Healthcare Companies, Inc. is nationally recognized as the incumbent leader in the delivery of “Retail Healthcare” products, end-to-end distribution and fulfillment services and innovative Digital Health solutions to U.S. healthcare providers and their consumers. iRemedy offers healthcare providers the ability to save costs on medical supplies and generate new and meaningful retail revenue streams through leading edge patient engagement tools and services offered on its proprietary platform. For more information, please visit www.iRemedySupply.com and www.iRemedy.com.